Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia.
Rosas I, Martínez C, Coto E, Clarimón J, Lleó A, Illán-Gala I, Dols-Icardo O, Borroni B, Almeida MR, van der Zee J, Van Broeckhoven C; EU EOD Consortium; Bruni AC, Anfossi M, Bernardi L, Maletta R, Serpente M, Galimberti D, Scarpini E, Rossi G, Caroppo P, Benussi L, Ghidoni R, Binetti G, Nacmias B, Sorbi S, Piaceri I, Bagnoli S, Antonell A, Sánchez-Valle R, De la Casa-Fages B, Grandas F, Diez-Fairen M, Pastor P, Ferrari R; IFGC; Queimaliños-Perez D, Pérez-Oliveira S, Álvarez V, Menéndez-González M. Rosas I, et al. Neurobiol Aging. 2021 Mar;99:99.e15-99.e22. doi: 10.1016/j.neurobiolaging.2020.08.018. Epub 2020 Sep 2. Neurobiol Aging. 2021. PMID: 32972771
Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease.
Rosas I, Martínez C, Clarimón J, Lleó A, Illán-Gala I, Dols-Icardo O, Borroni B, Almeida MR, van der Zee J, Van Broeckhoven C, Bruni AC, Anfossi M, Bernardi L, Maletta R, Serpente M, Galimberti D, Scarpini E, Rossi G, Caroppo P, Benussi L, Ghidoni R, Binetti G, Nacmias B, Sorbi S, Piaceri I, Bagnoli S, Antonell A, Sánchez-Valle R, De la Casa-Fages B, Grandas F, Diez-Fairen M, Pastor P, Ferrari R, Álvarez V, Menéndez-González M. Rosas I, et al. Neurobiol Aging. 2020 Mar;87:139.e1-139.e7. doi: 10.1016/j.neurobiolaging.2019.10.017. Epub 2019 Nov 1. Neurobiol Aging. 2020. PMID: 31810584
Cancer in Parkinson's Disease: An Approximation to the Main Risk Factors.
Rosas I, Morís G, Coto E, Blázquez M, Suárez E, García-Fernández C, Siso P, Martínez C, Pérez-Oliveira S, Álvarez V, Menéndez-González M. Rosas I, et al. Neurodegener Dis. 2021;21(1-2):36-41. doi: 10.1159/000520301. Epub 2021 Oct 21. Neurodegener Dis. 2021. PMID: 34673649
Smoking is associated with age at disease onset in Parkinson's disease.
Rosas I, Morís G, Coto E, Blázquez-Estrada M, Suárez E, García-Fernández C, Martínez C, Herrera ID, Pérez-Oliveira S, Álvarez V, Menéndez-González M; Spain_PD consortium. Rosas I, et al. Parkinsonism Relat Disord. 2022 Apr;97:79-83. doi: 10.1016/j.parkreldis.2022.03.005. Epub 2022 Mar 24. Parkinsonism Relat Disord. 2022. PMID: 35364453
Intermediate and Expanded HTT Alleles and the Risk for α-Synucleinopathies.
Pérez-Oliveira S, Álvarez I, Rosas I, Menendez-González M, Blázquez-Estrada M, Aguilar M, Corte D, Buongiorno M, Molina-Porcel L, Aldecoa I, Martí MJ, Sánchez-Juan P, Infante J, González-Aramburu I, García-González P, Rosende-Roca M, Boada M, Ruiz A, Periñán MT, Macías-García D, Muñoz-Delgado L, Gómez-Garre P, Mir P, Clarimón J, Lleo A, Alcolea D, De la Casa-Fages B, Duarte I, Álvarez V, Pastor P. Pérez-Oliveira S, et al. Among authors: rosas i. Mov Disord. 2022 Sep;37(9):1841-1849. doi: 10.1002/mds.29153. Epub 2022 Jul 19. Mov Disord. 2022. PMID: 35852957
Sodium interference in the determination of urinary aldosterone.
Aldea ML, Barallat J, Martín MA, Rosas I, Pastor MC, Granada ML. Aldea ML, et al. Among authors: rosas i. Clin Biochem. 2016 Feb;49(3):295-7. doi: 10.1016/j.clinbiochem.2015.11.004. Epub 2015 Nov 10. Clin Biochem. 2016. PMID: 26562029
319 results